1. 1002TiPBAROCCO: A randomized phase II study of weekly paclitaxel vs cediranib-olaparib with continuous schedule vs cediranib-olaparib with intermittent schedule in advanced platinum resistant ovarian cancer. (23rd October 2018) Authors: Colombo, N; Nicoletto, O; Benedetti Panici, P; Tognon, G; Lissoni, A A; Bologna, A; Tomao, F; Fossati, R; Tettamanzi, F; Rulli, E; Galli, F; Alvisi, M F; Torri, V; Biagioli, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of recent legislative bills regarding clinical research on Italian ethics committee activity. Issue 10 (30th September 2008) Authors: Porcu, L; Poli, D; Torri, V; Rulli, E; Di Tullio, M C; Cinquini, M; Bajetta, E; Labianca, R; Di Costanzo, F; Nitti, D; Floriani, I Journal: Journal of medical ethics Issue: Volume 34:Issue 10(2008) Page Start: 747 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P-134Real-world guideline application in the management of pancreatic cancer patients: the Italian GARIBALDI study. (2nd July 2019) Authors: Reni, M; Bergamo, F; Cavanna, L; Spada, M; Ghidini, M; Giommoni, E; Maiello, E; Artioli, F; Cardellino, G; Torri, V; Cinquini, M; Giugliano, V; Pinto, C Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗